A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma

Introduction Renal cell carcinoma (RCC) is one of the most usual kidney’s tumors. The improvement of non-invasive biomarkers will make it feasible to investigate whose have high risk of recurrence after radical or partial nephrectomy and will expand the valuation of tumor response to several treatm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Seyed Mohammad Kazem Aghamir, Mohadeseh Nasir Shirazi, Fatemeh Khatami
Formato:	article
Lenguaje:	EN
Publicado:	Urology Research Center 2021
Materias:	renal cell carcinoma circulating tumor cells molecular markers diagnosis Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/189a5c83a24547be873eaac6950b017a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:189a5c83a24547be873eaac6950b017a
record_format	dspace
spelling	oai:doaj.org-article:189a5c83a24547be873eaac6950b017a2021-11-27T06:02:24ZA Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma10.22034/TRU.2020.257587.10502717-042Xhttps://doaj.org/article/189a5c83a24547be873eaac6950b017a2021-02-01T00:00:00Zhttps://www.transresurology.com/article_120190.htmlhttps://doaj.org/toc/2717-042XIntroduction Renal cell carcinoma (RCC) is one of the most usual kidney’s tumors. The improvement of non-invasive biomarkers will make it feasible to investigate whose have high risk of recurrence after radical or partial nephrectomy and will expand the valuation of tumor response to several treatment strategies. In this perspective, liquid biopsy suggests a talented perception for cancer diagnosis and monitoring, with several benefits versus traditional RCC diagnostic processes and can be taken into account of the present RCC diagnosis and controlling strategies. Method In this systematic review, we considered both CTCs count and molecular markers in RCC patient management. A systematic search on several databases like PubMed, Scopus, Embase, and Web of Science was directed which led to the final 24 studies considering the impact of CTCs on both diagnosis and prognosis of RCC. Results Several primary studies consider the CTCs quantitation as the tumor representing components that are based on immunomagnetic separation procedure. The magnetic cell sorting (MACS) technique, cell search, Tapered-slit filter (photosensitive polymer-based microfilter), CELLection™ Dynabeads® coated with the monoclonal antibodies, and ISET® -Isolation by Size of Tumor cells. If CTCs wanted to be recruited for the prognosis of RCC and progression-free survival (PFS) it is better to check by gene expression profile through quantitative polymerase chain reaction analysis (Real Time-PCR) or in situ hybridization of CTC’s RNA molecules. Conclusions CTCs detection as the main liquid biopsy component has an excessive clinical impact on cancer management. Nevertheless, usual methods have some limitations when directing for the recognition of circulating tumor cells (CTCs) with high efficiency and low cost. Some CTCs molecular markers and gene expression profiling of CTCs should be considered for RCC prognosis. Seyed Mohammad Kazem AghamirMohadeseh Nasir ShiraziFatemeh KhatamiUrology Research Centerarticlerenal cell carcinomacirculating tumor cellsmolecular markersdiagnosisDiseases of the genitourinary system. UrologyRC870-923ENTranslational Research in Urology, Vol 3, Iss 1, Pp 10-18 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	renal cell carcinoma circulating tumor cells molecular markers diagnosis Diseases of the genitourinary system. Urology RC870-923
spellingShingle	renal cell carcinoma circulating tumor cells molecular markers diagnosis Diseases of the genitourinary system. Urology RC870-923 Seyed Mohammad Kazem Aghamir Mohadeseh Nasir Shirazi Fatemeh Khatami A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
description	Introduction Renal cell carcinoma (RCC) is one of the most usual kidney’s tumors. The improvement of non-invasive biomarkers will make it feasible to investigate whose have high risk of recurrence after radical or partial nephrectomy and will expand the valuation of tumor response to several treatment strategies. In this perspective, liquid biopsy suggests a talented perception for cancer diagnosis and monitoring, with several benefits versus traditional RCC diagnostic processes and can be taken into account of the present RCC diagnosis and controlling strategies. Method In this systematic review, we considered both CTCs count and molecular markers in RCC patient management. A systematic search on several databases like PubMed, Scopus, Embase, and Web of Science was directed which led to the final 24 studies considering the impact of CTCs on both diagnosis and prognosis of RCC. Results Several primary studies consider the CTCs quantitation as the tumor representing components that are based on immunomagnetic separation procedure. The magnetic cell sorting (MACS) technique, cell search, Tapered-slit filter (photosensitive polymer-based microfilter), CELLection™ Dynabeads® coated with the monoclonal antibodies, and ISET® -Isolation by Size of Tumor cells. If CTCs wanted to be recruited for the prognosis of RCC and progression-free survival (PFS) it is better to check by gene expression profile through quantitative polymerase chain reaction analysis (Real Time-PCR) or in situ hybridization of CTC’s RNA molecules. Conclusions CTCs detection as the main liquid biopsy component has an excessive clinical impact on cancer management. Nevertheless, usual methods have some limitations when directing for the recognition of circulating tumor cells (CTCs) with high efficiency and low cost. Some CTCs molecular markers and gene expression profiling of CTCs should be considered for RCC prognosis.
format	article
author	Seyed Mohammad Kazem Aghamir Mohadeseh Nasir Shirazi Fatemeh Khatami
author_facet	Seyed Mohammad Kazem Aghamir Mohadeseh Nasir Shirazi Fatemeh Khatami
author_sort	Seyed Mohammad Kazem Aghamir
title	A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
title_short	A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
title_full	A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
title_fullStr	A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
title_full_unstemmed	A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma
title_sort	systematic review of circulating tumor cells in renal cell carcinoma
publisher	Urology Research Center
publishDate	2021
url	https://doaj.org/article/189a5c83a24547be873eaac6950b017a
work_keys_str_mv	AT seyedmohammadkazemaghamir asystematicreviewofcirculatingtumorcellsinrenalcellcarcinoma AT mohadesehnasirshirazi asystematicreviewofcirculatingtumorcellsinrenalcellcarcinoma AT fatemehkhatami asystematicreviewofcirculatingtumorcellsinrenalcellcarcinoma AT seyedmohammadkazemaghamir systematicreviewofcirculatingtumorcellsinrenalcellcarcinoma AT mohadesehnasirshirazi systematicreviewofcirculatingtumorcellsinrenalcellcarcinoma AT fatemehkhatami systematicreviewofcirculatingtumorcellsinrenalcellcarcinoma
_version_	1718409150693638144

A Systematic Review of Circulating Tumor Cells in Renal Cell Carcinoma

Ejemplares similares